GeneXpert PCR market data – GAI passes validation exercise

The topic of PCR systems and how they can be used to rapidly test patients with Covid-19 is frequently hitting the headlines. An article published on the 21st March by Business Insider particularly interested us here at Global Asset Index: – ‘The FDA just approved a new rapid Covid-19 test that can diagnose the virus in 45 minutes.’ The article stated the number of GeneXpert systems in operation globally to be 23000, with 5000 of those based in the US (22% of total GeneXpert market). https://www.businessinsider.com/fda-approves-coronavirus-test-that-can-diagnose-in-45-minutes-2020-3?r=US&IR=T
GAI took the opportunity to compare the data published by Business Insider, with data gathered by text mining algorithms in the GAI equipment database. The validation exercise revealed results for GeneXpert systems to be within 1% of the official published data, proving the accuracy of our results.
We welcome any opportunity to validate our data, so please get in touch!